Abstract PS7-87: Incidence, treatment and survival of patients with brain metastases at initial metastatic breast cancer diagnosis: A real-world experience in national cancer center, China
Yiqun Li(Shanghai Pesticide Research Institute), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Yuan, Dainan Zhang(University of Electronic Science and Technology of China), Jiayu Wang(Nanjing University of Chinese Medicine), Ying Fan(Academy of Medical Sciences), Yang Luo(Kunming University), Hongnan Mo(Chinese Academy of Medical Sciences & Peking Union Medical College), Qing Li(Xiangnan University), Shanshan Chen(Chongqing University of Posts and Telecommunications), Ye Zhang(Inner Mongolia Medical University), Yimeng Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Zijing Wang(Qingdao University), Qiao Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Pin Zhang(Peking University), Shaoyan Lin(Nanjing Agricultural University), Xiuwen Guan(Chinese Academy of Medical Sciences & Peking Union Medical College), Ruigang Cai(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Ma(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 0
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k